PATENT CLAIM ANALYSIS

Application Number: 15745190
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "495000"]

Abstract:
The present invention concerns controlled-release multilayer microparticle containing a pharmaceutically active compound, said microparticle being intended for oral administration or direct administration in the stomach in the form of a liquid pharmaceutical composition. It concerns also the liquid pharmaceutical composition containing it, a kit for the preparation of said liquid pharmaceutical composition, a pharmaceutical solid composition intended to be reconstituted in the form of said liquid composition and a process of preparation of said liquid composition

Claim (Index 2):
The microparticle according to  claim 1 , wherein the pharmaceutically active compound is an acid labile pharmaceutically active compound or an unstable pharmaceutically active compound in acidic conditions, a pharmaceutically active compound which is aggressive for the gastric mucosa, a pharmaceutically active compound whose therapeutical efficacy needs to be improved or prolonged with a sustained-release layer or a pharmaceutically active compound who needs to target a section of the gastro-intestinal tract other than the stomach.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.95122
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14305935', '12639664', '13919499', '14195833', '12678406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.717929771265854
- 35 USC 102 Novelty (BERT): 0.5230056142791543
- Combined Prediction Score: 0.698437355567184
- Mean Citation Score: 240.780092
- Max Citation Score: 244.31242000000003
- Similarity Product: 134.87240799084188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test